DOCSLIB.ORG

Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family Downloaded from http://cshperspectives.cshlp.org/ on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family Hideo Negishi,1 Tadatsugu Taniguchi,1,2 and Hideyuki Yanai1,2 1Department of Molecular Immunology, Institute of Industrial Science, The University of Tokyo, Komaba 4-6-1, Meguro-ku, Tokyo 153-8505, Japan 2Max Planck-The University of Tokyo Center for Integrative Inflammology, Komaba 4-6-1, Meguro-ku, Tokyo 153-8505, Japan Correspondence: [email protected] Interferons (IFNs) are a broad class of cytokines elicited on challenge to the host defense and are essential for mobilizing immune responses to pathogens. Divided into three classes, type I, type II, and type III, all IFNs share in common the ability to evoke antiviral activities initiated by the interaction with their cognate receptors. The nine-member IFN regulatory factor (IRF) family, first discovered in the context of transcriptional regulation of type I IFN genes follow- ing viral infection, are pivotal for the regulation of the IFN responses. In this review, we briefly describe cardinal features of the three types of IFNs and then focus on the role of the IRF family members in the regulation of each IFN system. ll three classes of interferons (IFNs) are so quenced, and formally recognized to comprise a Anamed because of the shared property to related gene family (Knight 1975; Taniguchi interfere with viral replication in the host et al. 1979; Maeda et al. 1980; Rubinstein et al. (Weissmann and Weber 1986; Taniguchi 1988; 1981; Weissmann and Weber 1986; Taniguchi Stark et al. 1998; Levy and Garcia-Sastre 2001; 1988; Stark et al. 1998; Levy and Garcia-Sastre Samuel 2001; Katze et al. 2002; Pestka et al. 2004; 2001; Samuel 2001; Katze et al. 2002; Pestka et al. Platanias 2005; Vilcek 2006). It is perhaps not an 2004; Platanias 2005; Vilcek 2006). Type I IFNs exaggeration to say that the discovery of IFNs are principally expressed by innate immune cells provided the biggest impetus for the study of all (Hervas-Stubbs et al. 2011). Type II IFN, repre- cytokine research. Type I IFNs were initially dis- sented by a single gene product, IFN-γ, was rec- covered as soluble factors that mediated viral ognized for its antiviral activity induced by ac- interference. This is defined as the resistance tivated immune cells, typically by natural killer to virus infection induced by a prior viral infec- (NK) and T cells (Wheelock 1965; Gray et al. tion (Isaacs and Lindenmann 1957; Nagano and 1982). Type III IFNs (also called IFN-λ and ini- Kojima 1958). It was not until after two decades tially also called interleukin [IL]-28 and IL-29) of study that type I IFN genes were cloned, se- are restricted in their tissue distribution (e.g., are Editors: Warren J. Leonard and Robert D. Schreiber Additional Perspectives on Cytokines available at www.cshperspectives.org Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a028423 Cite this article as Cold Spring Harb Perspect Biol 2018;10:a028423 1 Downloaded from http://cshperspectives.cshlp.org/ on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press H. Negishi et al. not highly expressed in hematopoietic cells), ISGF3 (IFN-stimulated gene [ISG] factor 3) and act predominantly at epithelial surfaces that consists of STAT1, STAT2, and IRF9 (Tani- (Sheppard et al. 2003; Iversen and Paludan guchi and Takaoka 2001; Pestka et al. 2004; 2010). Decker et al. 2005; Ivashkiv and Donlin 2014). In this review, we first describe briefly the ISGF3 is a transcriptional activator that on cardinal features of the three types of IFNs in translocation to the nucleus binds IFN-stimulat- the context of the signal transduction pathways ed response elements (ISREs) in gene promoters they trigger and biological activities elicited and of IFN-inducible genes (ISGs) to initiate gene then focus on the regulation of these IFN re- transcription. On the other hand, IRF2, local- sponses by the IFN regulatory factor (IRF) tran- ized in the nucleus, functions as a transcriptional scription factor family. Of particular note, the attenuator of ISGF3-mediated transcriptional discovery of so-called innate immune receptors activation; hence, absence of IRF2 results in ex- beginning with Toll-like receptor 4 (Medzhitov cessive type I IFN signaling (Hida et al. 2000). et al. 1997) has provided the stimulus and con- IFNAR activation also results in the activation of text for understanding the regulatory mecha- STAT1 homodimers that bind and activate γ- nisms of IFNs by the IRF family transcription activated sequence (GAS) (IFN-γ activated se- factors. Because of space limitations, we are un- quence) motifs, leading to the induction of gene able to touch on various biological activities transcription (Decker et al. 2005). Although less manifested by IFNs but instead point the reader well characterized, type I IFN signaling may also to the many excellent reviews on the topic induce signaling of mitogen-activated protein (Pestka et al. 2004; Vilcek 2006; Tamura et al. kinase (MAPK)/c-Jun amino-terminal kinase 2008; Trinchieri 2010). (JNK) pathways (Platanias 2005). Type II IFN or IFN-γ is structurally unre- lated to the other two classes of IFN genes and THREE TYPES OF IFNs: A BRIEF OVERVIEW is best known as a critical cytokine secreted dur- The molecular characterization of IFNs began ing activated NK- and T-cell responses (Whee- when type I IFN genes were recognized to com- lock 1965; Grayet al. 1982). Further, IFN-γ binds prise a gene family (Taniguchi et al. 1980; Pestka a different cell-surface receptor consisting of et al. 2004; Vilcek 2006). The two best-charac- IFNGR1 and IFNGR2 subunits, which in turn terized and most broadly expressed genes of this associate with JAK1 and JAK2, respectively (Fig. subtype are IFN-α, encoded by more than a doz- 1). The activation of these kinases results in en genes, and IFN-β (single gene family) (Deck- STAT1 homodimerization and nuclear translo- er et al. 2005). Other type I IFN subtypes are cation that targets GAS DNA sequences. It is known, namely, IFN-ω, and IFN-τ, but remain worth noting that ISGF3 is also activated by the poorly characterized because of limited tissue IFN-γ signaling, albeit weakly (Takaoka et al. expression, overlapping function with IFN-α 2000). It was also shown that effective IFN-γ and IFN-β, and species-to-species differences signaling is contingent on a weak type I IFN (Pestka et al. 2004; Capobianchi et al. 2015). signaling caused by a low constitutive produc- All type I IFN classes bind to a heterodimeric tion of type I IFNs (Takaoka et al. 2000). receptor composed of two chains, IFNAR1 and Type III IFN or IFN-λs are the least charac- IFNAR2, which signal through recruitment of terized IFN family. Structurally related to type I Janus-activated kinases (JAKs) TYK2 and IFNs and to the IL-10 family (Pestka et al. 2004; JAK1, respectively (Fig. 1) (Taniguchi and Ta- Uze and Monneron 2007; Lazear et al. 2015), kaoka 2001; Pestka et al. 2004; Decker et al. 2005; this family includes IFN-λ1 (IL-28A), IFN-λ2 Ivashkiv and Donlin 2014). Activation of these (IL-28B), and IFN-λ3 (IL-29). IFN-λs bind to JAKs causes tyrosine phosphorylation of signal a heterodimeric cytokine receptor composed transducers and activators of transcription of an IL-28R-binding chain and IL-10R2 that (STAT)1 and STAT2, which in turn leads to is shared with the IL-10 family of cytokines the formation of a trimeric complex, called (Fig. 1) (Uze and Monneron 2007). Similar to 2 Cite this article as Cold Spring Harb Perspect Biol 2018;10:a028423 Downloaded from http://cshperspectives.cshlp.org/ on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press IFNs and the IRF Family Type I IFN Type II IFN Type III IFN IFNGR1 IFNGR2 IFNAR1 IFNAR2 IL10R2 IFNLR1 Cytoplasm JAK1 JAK1 JAK1 TYK2 TYK2 JAK1 JAK2 JAK2 STAT1 STAT1 STAT1 MAPK/JNK P P P P P P pathway P IRF9 P IRF9 STAT2 STAT2 ISGF3 STAT1GAF ISGF3 Nucleus ISRE GAS ISRE IRF2 Figure 1. Signal transduction by type I, type II, and type III interferon (IFN) receptors. A schematic view of the signal transduction pathways for the three types of IFN is shown. Type I IFN binds IFNAR2, leading to the subsequent recruitment of IFNAR1. IFN-β also forms a stable complex with IFNAR1 in an IFNAR2-indepe- nent manner, whereas IFN-α does not (de Weerd et al. 2013). The binding of type I IFN induces formation of a receptor complex between IFNAR-1 and IFNAR-2, leading to activation of the receptor-associated TYK2 and JAK1 kinases. This is followed by the tyrosine phosphorylation of signal transducers and activators of transcription (STAT)1 and STAT2 and, on recruitment of IFN regulatory factor (IRF)9, forms the heterotri- meric IFN-stimulated gene factor 3 (ISGF3) transcription factor complex. In addition, a STAT1 homodimer, termed IFN-γ-activated factor (GAF), is also formed. These transcriptional–activator complexes translocate into the nucleus and activate the IFN-stimulated regulatory elements (ISREs) or γ-activated sequences (GASs) promoter elements, for ISGF3, or GAF, respectively. IRF2 functions as a transcriptional attenuator of the ISGF3-mediated transcriptional activation. Type I IFN signaling may also induce signaling of mitogen-acti- vated protein kinase (MAPK)/c-Jun amino-terminal kinase (JNK) pathways. Type II IFN binds as a homo- dimer and induces dimerization of IFNGR1 subunits and recruitment of IFNGR2 subunits. This association causes the phosphorylation of JAK1 and JAK2 kinases, leading to phosphorylation of STAT1.
Load more

Recommended publications
  • Induction of a TRAIL Mediated Suicide Program by Interferon Alpha in Primary E€Usion Lymphoma
    Oncogene (2001) 20, 7029 ± 7040 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc Induction of a TRAIL mediated suicide program by interferon alpha in primary eusion lymphoma Ngoc L Toomey1,4, Vadim V Deyev2,4, Charles Wood3, Lawrence H Boise2, Duncan Scott1, Lei Hua Liu1, Lisa Cabral1, Eckhard R Podack2, Glen N Barber2 and William J Harrington Jr*,1 1Department of Medicine University of Miami School of Medicine, Miami, Florida, FL 33136, USA; 2Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida, FL 33136, USA; 3School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, NE 68588, USA Gammaherpes viruses are often detected in lymphomas Virus (EBV) or Human Herpes Virus Type 8 (HHV-8) arising in immunocompromised patients. We have found have been isolated from lymphomas found in im- that Azidothymidine (AZT) alone induces apoptosis in munosuppressed organ transplant recipients, children Epstein Barr Virus (EBV) positive Burkitt's lymphoma with hereditary immunode®ciencies and patients with (BL) cells but requires interferon alpha (IFN-a) to induce acquired immunode®ciency (AIDS) (Swinnen, 1999; apoptosis in Human Herpes Virus Type 8 (HHV-8) Goldsby and Carroll, 1998; Knowles, 1999). Many of positive Primary Eusion Lymphomas (PEL). Our these tumors can be categorized into distinct subtypes analysis of a series of AIDS lymphomas revealed that based on a variety of morphologic and molecular IFN-a selectively induced very high levels of the Death criteria. For example, AIDS associated large cell Receptor (DR) tumor necrosis factor-related apoptosis- diuse or immunoblastic lymphomas (DLCL, IBL) inducing ligand (TRAIL) in HHV-8 positive PEL lines are often EBV positive while AIDS associated Burkitt's and primary tumor cells whereas little or no induction lymphomas (BL) less frequently contain EBV (Gaidano was observed in primary EBV+ AIDS lymphomas and et al., 1994).
    [Show full text]
  • Correlation of Cytokine Level with the Severity of Severe Fever With
    Liu et al. Virology Journal (2017) 14:6 DOI 10.1186/s12985-016-0677-1 RESEARCH Open Access Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome Miao-Miao Liu1, Xiao-Ying Lei1, Hao Yu2, Jian-zhi Zhang3 and Xue-jie Yu1,4* Abstract Background: Severe fever with thrombocytopenia syndrome (SFTS) was an emerging hemorrhagic fever that was caused by a tick-borne bunyavirus, SFTSV. Although SFTSV nonstructural protein can inhibit type I interferon (IFN-I) production Ex Vivo and IFN-I played key role in resistance SFTSV infection in animal model, the role of IFN-I in patients is not investigated. Methods: We have assayed the concentration of IFN-α, a subtype of IFN-I as well as other cytokines in the sera of SFTS patients and the healthy population with CBA (Cytometric bead array) assay. Results: The results showed that IFN-α, tumor necrosis factor (TNF-α), granulocyte colony-stimulating factor (G-CSF), interferon-γ (IFN-γ), macrophage inflammatory protein (MIP-1α), interleukin-6 (IL-6), IL-10, interferon-inducible protein (IP-10), monocyte chemoattractant protein (MCP-1) were significantly higher in SFTS patients than in healthy persons (p < 0.05); the concentrations of IFN-α, IFN-γ, G-CSF, MIP-1α, IL-6, and IP-10 were significant higher in severe SFTS patients than in mild SFTS patients (p < 0.05). Conclusion: The concentration of IFN-α as well as other cytokines (IFN-γ, G-CSF, MIP-1α, IL-6, and IP-10) is correlated with the severity of SFTS, suggesting that type I interferon may not be significant in resistance SFTSV infection in humans and it may play an import role in cytokine storm.
    [Show full text]
  • MST1 Is a Key Regulator of Beta Cell Apoptosis and Dysfunction in Diabetes
    ARTICLES MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes Amin Ardestani1, Federico Paroni1,6, Zahra Azizi1,6, Supreet Kaur1,6, Vrushali Khobragade1, Ting Yuan1, Thomas Frogne2, Wufan Tao3, Jose Oberholzer4, Francois Pattou5, Julie Kerr Conte5 & Kathrin Maedler1 Apoptotic cell death is a hallmark of the loss of insulin-producing beta cells in all forms of diabetes mellitus. Current treatments fail to halt the decline in functional beta cell mass, and strategies to prevent beta cell apoptosis and dysfunction are urgently needed. Here, we identified mammalian sterile 20–like kinase-1 (MST1) as a critical regulator of apoptotic beta cell death and function. Under diabetogenic conditions, MST1 was strongly activated in beta cells in human and mouse islets and specifically induced the mitochondrial-dependent pathway of apoptosis through upregulation of the BCL-2 homology-3 (BH3)-only protein BIM. MST1 directly phosphorylated the beta cell transcription factor PDX1 at T11, resulting in the latter’s ubiquitination and degradation and thus in impaired insulin secretion. MST1 deficiency completely restored normoglycemia, beta cell function and survival in vitro and in vivo. We show MST1 as a proapoptotic kinase and key mediator of apoptotic signaling and beta cell dysfunction and suggest that it may serve as target for the development of new therapies for diabetes. Pancreatic beta cell death is the fundamental cause of type 1 diabetes of events, which makes the initiation of beta cell death complex and (T1D) and a contributing factor to the reduced beta cell mass in type 2 its blockade difficult to successfully achieve in vivo.
    [Show full text]
  • Porvac® Subunit Vaccine E2-CD154 Induces Remarkable Rapid Protection Against Classical Swine Fever Virus
    Article Porvac® Subunit Vaccine E2-CD154 Induces Remarkable Rapid Protection against Classical Swine Fever Virus Yusmel Sordo-Puga 1, Marisela Suárez-Pedroso 1 , Paula Naranjo-Valdéz 2, Danny Pérez-Pérez 1, Elaine Santana-Rodríguez 1, Talia Sardinas-Gonzalez 1, Mary Karla Mendez-Orta 1, Carlos A. Duarte-Cano 1, Mario Pablo Estrada-Garcia 1 and María Pilar Rodríguez-Moltó 1,* 1 Animal Biotechnology Department, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana 10600, Cuba; [email protected] (Y.S.-P.); [email protected] (M.S.-P.); [email protected] (D.P.-P.); [email protected] (E.S.-R.); [email protected] (T.S.-G.); [email protected] (M.K.M.O.); [email protected] (C.A.D.); [email protected] (M.P.E.) 2 Central Laboratory Unit for Animal Health (ULCSA), Havana 11400, Cuba; [email protected] * Correspondence: [email protected]; Tel.: +53-7-2504419 Abstract: Live attenuated C-strain classical swine fever vaccines provide early onset protection. These vaccines confer effective protection against the disease at 5–7 days post-vaccination. It was previously reported that intramuscular administration of the Porvac® vaccine protects against highly virulent Citation: Sordo-Puga, Y.; classical swine fever virus (CSFV) “Margarita” strain as early as seven days post-vaccination. In Suárez-Pedroso, M.; Naranjo-Valdéz, order to identify how rapidly protection against CSFV is conferred after a single dose of the Porvac® P.; Pérez-Pérez, D.; subunit vaccine E2-CD154, 15 swine, vaccinated with a single dose of Porvac®, were challenged Santana-Rodríguez, E.; 3 intranasally at five, three, and one day post-vaccination with 2 × 10 LD50 of the highly pathogenic Sardinas-Gonzalez, T.; Mendez-Orta, Cuban “Margarita” strain of the classical swine fever virus.
    [Show full text]
  • Viral Resistance and IFN Signaling in STAT2 Knockout Fish Cells Carola E
    Viral Resistance and IFN Signaling in STAT2 Knockout Fish Cells Carola E. Dehler, Katherine Lester, Giulia Della Pelle, Luc Jouneau, Armel Houel, Catherine Collins, Tatiana Dovgan, This information is current as Radek Machat, Jun Zou, Pierre Boudinot, Samuel A. M. of September 26, 2021. Martin and Bertrand Collet J Immunol published online 29 May 2019 http://www.jimmunol.org/content/early/2019/05/28/jimmun ol.1801376 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2019/05/28/jimmunol.180137 Material 6.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 26, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published May 29, 2019, doi:10.4049/jimmunol.1801376 The Journal of Immunology Viral Resistance and IFN Signaling in STAT2 Knockout Fish Cells Carola E. Dehler,* Katherine Lester,† Giulia Della Pelle,‡ Luc Jouneau,‡ Armel Houel,‡ Catherine Collins,† Tatiana Dovgan,*,† Radek Machat,‡,1 Jun Zou,*,2 Pierre Boudinot,‡ Samuel A.
    [Show full text]
  • A Molecular Switch from STAT2-IRF9 to ISGF3 Underlies Interferon-Induced Gene Transcription
    ARTICLE https://doi.org/10.1038/s41467-019-10970-y OPEN A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription Ekaterini Platanitis 1, Duygu Demiroz1,5, Anja Schneller1,5, Katrin Fischer1, Christophe Capelle1, Markus Hartl 1, Thomas Gossenreiter 1, Mathias Müller2, Maria Novatchkova3,4 & Thomas Decker 1 Cells maintain the balance between homeostasis and inflammation by adapting and inte- grating the activity of intracellular signaling cascades, including the JAK-STAT pathway. Our 1234567890():,; understanding of how a tailored switch from homeostasis to a strong receptor-dependent response is coordinated remains limited. Here, we use an integrated transcriptomic and proteomic approach to analyze transcription-factor binding, gene expression and in vivo proximity-dependent labelling of proteins in living cells under homeostatic and interferon (IFN)-induced conditions. We show that interferons (IFN) switch murine macrophages from resting-state to induced gene expression by alternating subunits of transcription factor ISGF3. Whereas preformed STAT2-IRF9 complexes control basal expression of IFN-induced genes (ISG), both type I IFN and IFN-γ cause promoter binding of a complete ISGF3 complex containing STAT1, STAT2 and IRF9. In contrast to the dogmatic view of ISGF3 formation in the cytoplasm, our results suggest a model wherein the assembly of the ISGF3 complex occurs on DNA. 1 Max Perutz Labs (MPL), University of Vienna, Vienna 1030, Austria. 2 Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna 1210, Austria. 3 Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna 1030, Austria. 4 Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna 1030, Austria.
    [Show full text]
  • Age- and Gender-Specific Modulation of Serum Osteopontin and Interferon-Α by Osteopontin Genotype in Systemic Lupus Er
    Genes and Immunity (2009) 10, 487–494 & 2009 Macmillan Publishers Limited All rights reserved 1466-4879/09 $32.00 www.nature.com/gene ORIGINAL ARTICLE Age- and gender-specific modulation of serum osteopontin and interferon-a by osteopontin genotype in systemic lupus erythematosus SN Kariuki1, JG Moore1, KA Kirou2,MKCrow2, TO Utset1 and TB Niewold1 1Section of Rheumatology, University of Chicago, Chicago, IL, USA and 2Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY, USA Osteopontin (OPN) is a multifunctional cytokine involved in long bone remodeling and immune system signaling. Additionally, OPN is critical for interferon-a (IFN-a) production in murine plasmacytoid dendritic cells. We have previously shown that IFN-a is a heritable risk factor for systemic lupus erythematosus (SLE). Genetic variants of OPN have been associated with SLE susceptibility, and one study suggests that this association is particular to men. In this study, the 3 0 UTR SLE-risk variant of OPN (rs9138C) was associated with higher serum OPN and IFN-a in men (P ¼ 0.0062 and P ¼ 0.0087, respectively). In women, the association between rs9138 C and higher serum OPN and IFN-a was restricted to younger subjects, and risk allele carriers showed a strong age-related genetic effect of rs9138 genotype on both serum OPN and IFN-a (Po0.0001). In African- American subjects, the 5 0 region single nucleotide polymorphisms, rs11730582 and rs28357094, were associated with anti- RNP antibodies (odds ratio (OR) ¼ 2.9, P ¼ 0.0038 and OR ¼ 3.9, P ¼ 0.021, respectively). Thus, we demonstrate two distinct genetic influences of OPN on serum protein traits in SLE patients, which correspond to previously reported SLE-risk variants.
    [Show full text]
  • IL-12 Abrogates Calcineurin-Dependent Immune Evasion During Leukemia Progression
    Author Manuscript Published OnlineFirst on May 29, 2019; DOI: 10.1158/0008-5472.CAN-18-3800 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. IL-12 abrogates calcineurin-dependent immune evasion during leukemia progression Jennifer L. Rabe,1* Lori Gardner,2* Rae Hunter,3 Jairo A. Fonseca,3 Jodi Dougan,3 Christy M. Gearheart,2 Michael S. Leibowitz,2 Cathy Lee-Miller,2 Dmitry Baturin,2 Susan P. Fosmire,2 Susan E. Zelasko,2 Courtney L. Jones,2 Jill E. Slansky,4 Manali Rupji,5 Bhakti Dwivedi,5 Curtis J. Henry,3,5,6 and Christopher C. Porter3,5,6 Affiliations: 1Molecular Biology Program, University of Colorado Denver, Aurora, CO. 2Department of Pediatrics, University of Colorado, Aurora, CO 3Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 4Integrated Department of Immunology, University of Colorado School of Medicine, Aurora, CO 5Winship Cancer Institute, Emory University, Atlanta, GA 6Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, GA JR and LAG contributed equally to this study. Corresponding Author: Christopher C. Porter, MD Emory University School of Medicine 1760 Haygood Drive, E370 Atlanta, GA 30322 Phone: 404-727-4881 Fax: 404-727-4455 [email protected] Running title: Leukemia-cell calcineurin drives immune evasion Conflict of interest statement The authors have declared that no conflicts of interest exist. Abstract: 199 words Main Text: 5797 words (excluding figure legends and references) Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on May 29, 2019; DOI: 10.1158/0008-5472.CAN-18-3800 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Human IL12A / NKSF1 Protein (His Tag)
    Human IL12A / NKSF1 Protein (His Tag) Catalog Number: 10021-H08H General Information SDS-PAGE: Gene Name Synonym: CLMF; IL-12A; NFSK; NKSF1; P35 Protein Construction: A DNA sequence encoding the p35 subunit of human IL12, termed as IL12A (P29459) (Met 1-Ser 219) was expressed, fused with a polyhistidine tag at the C-terminus. Source: Human Expression Host: HEK293 Cells QC Testing Purity: > 92 % as determined by SDS-PAGE Bio Activity： Protein Description Measured by its ability to bind Human IL12B-his in functional ELISA. Interleukin-12 subunit alpha (IL12A/IL-12p35) is also known as Cytotoxic lymphocyte maturation factor 35 kDa subunit, cytotoxic lymphocyte Endotoxin: maturation factor 1, p35, NK cell stimulatory factor chain 1, and interleukin- 12 alpha chain. IL12A/IL-12p35 is a subunit of a cytokine that acts on T < 1.0 EU per μg of the protein as determined by the LAL method and natural killer cells, and has a broad array of biological activities. The cytokine is a disulfide-linked heterodimer composed of the 35-kD subunit Stability: encoded by this gene, and a 40-kD subunit that is a member of the Samples are stable for up to twelve months from date of receipt at -70 ℃ cytokine receptor family. IL12A/IL-12p35 is required for the T-cell- independent induction of IFN-gamma, and is important for the Predicted N terminal: Arg 23 differentiation of both Th1 and Th2 cells. The responses of lymphocytes to this cytokine are mediated by the activator of transcription protein STAT4. Molecular Mass: Nitric oxide synthase 2A (NOS2A/NOS2) is found to be required for the signaling process of this cytokine in innate immunity.
    [Show full text]
  • Interferon-Γ Enhances Interleukin 12 Production in Rheumatoid Synovial
    Interferon-γ Enhances Interleukin 12 Production in Rheumatoid Synovial Cells via CD40-CD154 Dependent and Independent Pathways MINETAKE KITAGAWA, HIROSHI SUZUKI, YOSHIHIRO ADACHI, HIROSHI NAKAMURA, SHINICHI YOSHINO, and TAKAYUKI SUMIDA ABSTRACT. Objective. To determine the role of interferon-γ (IFN-γ) in CD40-CD154 dependent production of interleukin 12 (IL-12) by synovial cells of patients with rheumatoid arthritis (RA). Methods. We examined the effects of IFN-γ, tumor necrosis factor-α (TNF-α), and granulocyte- macrophage colony stimulating factor (GM-CSF) on CD40 expression on CD68+ synovial macrophage-lineage cells (SMC). The effects of IFN-γ and soluble CD154 (sCD154) on IL-12 production by RA synovial cells were determined by ELISA. Results. CD68+ SMC expressed substantial levels of CD40. IFN-γ, but not TNF-α or GM-CSF, markedly upregulated CD40 expression on CD68+ SMC. IFN-γ also dose dependently increased IL- γ 12 production by synovial cells. The effects of IFN- on CD40 expression (EC50 = 127.4 U/ml) were observed at a concentration 19 times lower than the effects on IL-12 production (EC50 = 6.8 U/ml). Treatment with IFN-γ at a concentration low enough to augment CD40 expression but not IL-12 production enhanced spontaneous IL-12 production synergy with sCD154. The synergistic enhance- ment of spontaneous IL-12 production was abrogated by CD40-Fc. In contrast, IL-12 production induced by high concentration of IFN-γ was not neutralized by CD40-Fc. Conclusion. IFN-γ enhanced IL-12 production via both CD40-CD154 dependent and independent pathways in RA synovium. IFN-γ may play a crucial role in the development of RA synovitis through regulation of IL-12 production.
    [Show full text]
  • Role of Perforin-2 in Regulating Type I Interferon Signaling
    https://www.scientificarchives.com/journal/journal-of-cellular-immunology Journal of Cellular Immunology Review Article Role of Perforin-2 in Regulating Type I Interferon Signaling Gregory V Plano, Noula Shembade* Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center Miller School of Medicine, University of Miami, Miami, FL 33136, USA *Correspondence should be addressed to Noula Shembade; [email protected] Received date: November 21, 2020, Accepted date: February 02, 2021 Copyright: © 2021 Plano G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Sepsis is a systemic inflammatory response caused by a harmful host immune reaction that is activated in response to microbial infections. Infection-induced type I interferons (IFNs) play critical roles during septic shock. Type I IFNs initiate their biological effects by binding to their transmembrane interferon receptors and initiating the phosphorylation and activation of tyrosine kinases TYK2 and JAK1, which promote phosphorylation and activation of STAT molecules. Type I IFN-induced activation of JAK/STAT pathways is a complex process and not well understood. Improper regulation of type I IFN responses can lead to the development of infectious and inflammation-related diseases, including septic shock, autoimmune diseases, and inflammatory syndromes. This review is mainly focused on the possible mechanistic roles of the transmembrane Perforin-2 molecule in the regulation of type I IFN- induced signaling. Keywords: JAK/STAT, Interferons, TYK2, STATs, Perforin-2, IFNAR1, IFNAR2 and Signaling Introduction and activator of transcription 2), respectively, under normal physiological conditions [4,5].
    [Show full text]
  • Recombinant Human IL12 Protein,HEK293 Expressed Catalog # AMS.IL2-H4210 for Research and Further Cell Culture Manufacturing Use
    Recombinant Human IL12 Protein,HEK293 Expressed Catalog # AMS.IL2-H4210 For Research and Further Cell Culture Manufacturing Use Description Source Recombinant Human IL12 Protein,HEK293 Expressed (Human IL12B & IL12A heterodimer) Ile 23 - Ser 328 (Accession # (AAH67499,IL12B) and Arg 23 - Ser 219 (P29459,IL12A)) was produced in human 293 cells (HEK293) Predicted N‐terminus Ile 23 (IL12B) and Arg 23 (IL12A) Molecular Human IL12B & IL12A heterodimer contains no "tag", and has a calculated MW of 36.6 kDa (IL12B) and 23.8 kDa (IL12A). The Characterization predicted N-terminus is Ile 23 (IL12B) and Arg 23 (IL12A). DTT-reduced Protein migrates as 33-47 kDa in SDS-PAGE due to glycosylation. Endotoxin Less than 1.0 EU per μg of the Human IL12B & IL12A heterodimer by the LAL method. Purity >95% as determined by SDS-PAGE. Bioactivity The bio-activity was determined by the dose-dependent release of IFN-gamma from the human NK92 cell line in presence of 20 ng/mL rhIL-2 (Catalog # IL2-H4216). The ED50 < 0.2 ng/mL, corresponding to a specific activity of >5,000,000 Unit/mg. Formulation and Storage Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization. Contact us for customized product form or formulation. Reconstitution See Certificate of Analysis for reconstitution instructions and specific concentrations. Storage Lyophilized Protein should be stored at -20℃ or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20℃ or -70℃. Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: ● 4-8℃ for 12 months in lyophilized state; ● -70℃ for 3 months under sterile conditions after reconstitution.
    [Show full text]